| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/19/2008 | US20080146492 Insulin production methods and pro-insulin constructs |
| 06/19/2008 | US20080146460 Optical probes and assays |
| 06/19/2008 | US20080145888 Assessment method |
| 06/19/2008 | US20080145884 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 06/19/2008 | US20080145866 Modified human thymic stromal lymphopoietin |
| 06/19/2008 | US20080145855 Mutations in the Ferroportin 1 Gene Associated with Hereditary Haemochromatosis |
| 06/19/2008 | US20080145465 Sesquiterpene lactone extract from artemisia leucodes for reducing inflammation and down-regulating pro-inflammatory gene expression |
| 06/19/2008 | US20080145463 Extracted from seeds of bitter gourd (Momordica charantia); exhibits specific cohesion relative to H-antigen on a red blood cell membrane or an erythrocyte membrane |
| 06/19/2008 | US20080145454 Dosage form Rhus toxicondendron; Ranunculus bulbosus; Phytolacca decandra; and Malus pumila |
| 06/19/2008 | US20080145448 mixture with Calcium Iodate, and Calcium Carbonate for removal of all three radionuclides Cesium, Strontium, Iodine |
| 06/19/2008 | US20080145438 Melting a drug in a molten miscible surfactant; heating the mixture; and cooling the mixture while continuously mixing under high; maximizing precipitation of drug particles coated with the surfactant and having a greater rate of dissolution than pure unprocessed drug |
| 06/19/2008 | US20080145429 Dosage Form Containing Oxycodone and Naloxone |
| 06/19/2008 | US20080145397 Multi-formed collagenous biomaterial medical device |
| 06/19/2008 | US20080145395 Multi-formed collagenous biomaterial medical device |
| 06/19/2008 | US20080145382 (CTLA-4, Cytotoxic T-Lymphocyte Antigen-4); vaccines, feline immunomodulators, antitumor agents; treating feline viral diseases; veterinary medicine |
| 06/19/2008 | US20080145373 Hepatitis B surface antigens; keyhole limpet hemocyanin; albumin; heat shock proteins |
| 06/19/2008 | US20080145371 SYNTHESIS OF HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES |
| 06/19/2008 | US20080145370 Multimeric immunoglobulin for use in prevention and treatment of viral and microorganismal infection |
| 06/19/2008 | US20080145366 Platelet derived growth factor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders; antisense agents; antitumor agents |
| 06/19/2008 | US20080145364 Method for High Throughput Screening for Anitbodies and Proteins Inducing Apoptosis |
| 06/19/2008 | US20080145363 Using vascular endothelial growth factor specific immunoglobulin as tool in diagnosis, prevention and treatment of cell proliferative, respiratory, vision and inflammatory disorders |
| 06/19/2008 | US20080145362 Antibody combination useful for tumor therapy |
| 06/19/2008 | US20080145359 Imaging, diagnosis and treatment of disease |
| 06/19/2008 | US20080145356 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides |
| 06/19/2008 | US20080145351 Using protein kinase m-zeta inhibitor as therapeutic in treatment of alcohol addiction, post-traumatic disorder, and phobia |
| 06/19/2008 | US20080145343 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 06/19/2008 | US20080145341 Stabilised Compositions Comprising Probiotics |
| 06/19/2008 | US20080145315 Bioassay for monitoring protein-protein interactions associated with absorption, distribution, metabolism and excretion in animals and/or cells |
| 06/19/2008 | US20080145314 EGFR inhibitors promote axon regeneration |
| 06/19/2008 | DE102006061517A1 Angioinhibin Angioinhibin |
| 06/19/2008 | CA2673097A1 Fused heterocyclic compound |
| 06/19/2008 | CA2672591A1 Treating agent of uropathy |
| 06/19/2008 | CA2672581A1 Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same |
| 06/19/2008 | CA2672565A1 Imidazothiazole derivatives |
| 06/19/2008 | CA2672176A1 1-phenyl 1-thio-d-glucitol derivative |
| 06/19/2008 | CA2672055A1 Treatment of cachexia |
| 06/19/2008 | CA2672044A1 Use of prodrugs of gaba analogs for treating diseases |
| 06/19/2008 | CA2671806A1 Remotely triggered release from heatable surfaces |
| 06/18/2008 | EP1932856A2 IL-8 inhibitors |
| 06/18/2008 | EP1932841A1 Sulfonamide compound |
| 06/18/2008 | EP1932840A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 06/18/2008 | EP1932839A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity |
| 06/18/2008 | EP1932543A2 Combination therapy for osteoporosis consisting of an estrogen agonist/antagonist and a growth hormone secretagogue |
| 06/18/2008 | EP1932541A1 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent |
| 06/18/2008 | EP1932535A2 Stimulation of beta cell profileration |
| 06/18/2008 | EP1932534A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 06/18/2008 | EP1932530A1 Agent for enhancing collagen production and utilization of the same |
| 06/18/2008 | EP1932522A1 Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease |
| 06/18/2008 | EP1931345A2 Methods for treatment of thiol-containing compound deficient conditions |
| 06/18/2008 | EP1617839B1 The use of azetidinecarboxamide derivatives in therapy |
| 06/18/2008 | EP1485378B1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/18/2008 | EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 06/18/2008 | EP1283830B1 Para-amine substituted phenylamide glucokinase activators |
| 06/18/2008 | EP1257648B1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 06/18/2008 | EP1228203B1 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 06/18/2008 | EP1222192B1 Hexahydrofuro¬2,3-b furan-3-yl-n- 3-¬(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino -1-benzyl-2-hydroxypropyl carbamate as retroviral protease inhibitor |
| 06/18/2008 | EP1115879B1 Retroviral particles protected against complement mediated destruction |
| 06/18/2008 | EP1064027B1 Apo-2 ligand-anti-her-2 antibody synergism |
| 06/18/2008 | EP0914829B1 Preventives and/or remedies for multiple organ failure |
| 06/18/2008 | EP0885210B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use |
| 06/18/2008 | CN101203243A Remedy for xanthoma |
| 06/18/2008 | CN101203223A Pharmaceutical composition comprising amorphous rosiglitazone |
| 06/18/2008 | CN101200469A Separation of regioisomers of metal phthalocyanines |
| 06/18/2008 | CN101199838A Lactase powders and preparing method thereof |
| 06/18/2008 | CN101199558A Compound probiotics for poultry and preparing method thereof |
| 06/18/2008 | CN101199538A Fructose two-phosphoric acid Na capsule and preparing method thereof |
| 06/18/2008 | CN101199537A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199529A Function of tetrandrine in preparing liver scathing-prevention medicament |
| 06/18/2008 | CN101199512A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199503A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199502A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199501A HIF hydroxylase inhibitors |
| 06/18/2008 | CN101199400A Consciousness-restoring wet tissue |
| 06/18/2008 | CN101199339A Galangal fruit health-care sausage |
| 06/18/2008 | CN100395245C Microcrystal |
| 06/18/2008 | CN100394981C Human granulocyte-macrophage colony stimulating factor spray and its preparation process |
| 06/18/2008 | CN100394979C Use of composition in preparing medicament for preventing and treating lethargy |
| 06/18/2008 | CN100394963C Medicine for treating female chronic fatigue syndrome and its preparing process |
| 06/18/2008 | CN100394928C Application of Antrodia camphorata mycelium fermented extract in preparation of anti-radiation damage medicine |
| 06/18/2008 | CN100394916C Method for providing nutraceutical or phytoceutical benefits and inhibiting oxidation using cherry derivatives |
| 06/18/2008 | CN100394860C Extracts of cacao bean and cacao bean husk with inhibitory effects on carcinogenesis |
| 06/17/2008 | USRE40387 7,11-dihydroxy 8,8,10,12,16-pentamethyl-3-(1-methyl-2-(2-methyl-4-thiazolyl) ethenyl-17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione and neutralizing buffer in an amount sufficient to reduce its decomposition; increasing the bioavailability of orally administered epothilones; anticarcinogenic agent |
| 06/17/2008 | US7388078 Nucleic acids encoding polypeptides having chips activity |
| 06/17/2008 | US7388026 Antitumor antibiotic; water solubility, stability; N-[2-{(1-chloromethyl)-1,2-dihydro-5-[(4-methylpiperazino)carbonyloxy]-3H-benz(e)indol-3-yl}carbonyl]-1H-indol-5-yl]-5-[(3-methyldithio-1-oxopropyl)-amino]-1H-indole-2-carboxamide |
| 06/17/2008 | US7388020 Compounds for chronic obstructive pulminary disorders for breathingand respiratory system diorders |
| 06/17/2008 | US7388015 inhibitors of cyclin-dependent kinases (CDKs); cancer, leukemia, psoriasis |
| 06/17/2008 | US7388011 Inhibiting the proteolytic activity of cathepsin S; 4-{3-[5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxy-propyl}-3,4,5,6-tetrahydro-2H-[1,2']bipyrazinyl-3'-carbonitrile; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 06/17/2008 | US7388010 fused hexacyclic derivatives consist of pyrrolidine, indazolone, quuinoxalinone rings; cyclin-dependent kinase inhibitor with cell growth-inhibitory activity; anticarcinogenic and antiproliferative agent |
| 06/17/2008 | US7388006 Non-steroidal progesting |
| 06/17/2008 | US7387879 Diagnosis of tauopathies |
| 06/17/2008 | US7387800 Mixture containing plant extract; renin, angiogenesis inhibitor; cardiovascular disorders; antidiabetic agents; liver disorders; gall stones; gastrointestinal disorders |
| 06/17/2008 | US7387791 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems |
| 06/17/2008 | US7387781 Agents for treating osteoporosis and inhibiting osteoclast formation |
| 06/17/2008 | US7387778 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
| 06/17/2008 | US7387777 Methods of treating hemophilia or von willebrand disease with p-selectin |
| 06/17/2008 | US7387771 dissolving in carrier liquid; drug linked to a protein-binding molecule via a spacer which is cleaved hydrolytically or enzymatically in the body of a subject in a pH-dependent manner; tissue targeted delivery; Doxorubicin-phenylacetylhydrazone spacer-maleimide |
| 06/17/2008 | CA2451990C A new compound for the treatment of impotence |
| 06/17/2008 | CA2444053C Fused bicyclic or tricyclic amino acids |
| 06/17/2008 | CA2439152C Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/17/2008 | CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |